الفهرس 
COVID-19Only 14 pages are availabe for public view
 |  | from | 204 |  |  |
| | | from | 204 | | |
Abstract
The COVID-19 pandemic has had a significant impact on mental health and has been associated with increased rates of psychiatric issues. Some key points about the mental health burdens linked to the pandemic include Increased levels of stress, anxiety and depression in the general population due to factors like social isolation, fears about the virus, economic hardship, etc.
The incidence of GHQ-28 positivity was 55.8% among the study group, Among the GHQ-28 positive patients, psychiatric disorders included anxiety (41.6%), depression (37.4%), substance abuse (8.3%), somatic symptoms (6.1%), eating disorder (2.4%), and adjustment disorder (4.1%),Anxiety and depression severity levels were assessed using Taylor Manifest Anxiety Scale and Beck Depression Inventory, showing various degrees of severity among patients,Substance use disorders were observed in 8.3% of GHQ-28 positive patients, with different substances and patterns of use reported, Somatic disorders were present in 6.1% of GHQ-28 positive patients, with somatic symptoms disorder and illness anxiety disorder being notable.
There is Significant associations were found between GHQ-28 positivity and factors such as smoking, medical comorbidities, hospitalization, and cortisone treatment, Correlation analyses revealed significant associations between psychiatric disorders (anxiety, depression) and factors like smoking, hospitalization, and treatment with cortisone.
The Univariate and multivariate regression analyses identified smoking, medical comorbidities, hospitalization, and cortisone treatment as significant predictors of GHQ-28 positivity. However, in multivariate analysis, medical comorbidities, hospitalization, and cortisone treatment emerged as the best independent predictors of GHQ-28 positivity.
Overall, the study provided insights into the prevalence of psychiatric disorders, risk factors, and predictors of psychological distress among COVID-19 survivors.
Proposed strategies to mitigate adverse psychological effects in future pandemics include smoking cessation programs, ensuring adequate management of chronic medical conditions, reducing unnecessary hospitalizations, providing mental health resources and support especially for hospitalized patients, carefully monitoring those on steroids, and improving accessibility of psychiatric services. Further research on protective factors and effective interventions is warranted.